Dec 112017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA – Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company discovering and developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections, today announced that Blake Wise, currently Achaogen's President and Chief Operating Officer, will succeed Kenneth Hillan, M.B.… => Read more

Achaogen announces COO Blake Wise to its Board of Directors as next CEO

From:: Achaogen announces COO Blake Wise to its Board of Directors as next CEO

Sorry, the comment form is closed at this time.

%d bloggers like this: